Skip to main content
AI Market Watch
Loading...

Matresa

Category: AI in Healthcare

Matresa is a clinical-grade, AI-powered preventative maternal health platform providing early screening, risk identification, and continuous personalised support for women from pregnancy through postpartum and return to work. Matresa was founded in 2025. The company is led by Mari-Carmen Sanchez-Morris. Based in Leamington Spa, Warwickshire, United Kingdom. Team size: 2-10. Total funding raised: $397,000. Latest round: Pre-Seed. Key investors include SFC Capital.

Founded
2025
Headquarters
Leamington Spa, Warwickshire, United Kingdom
Team size
2-10
Total funding
$397,000

Value proposition

Shifts maternal care from reactive to preventative by combining clinical expertise, behavioural science, and AI to provide continuous, personalised support between appointments, reducing preventable complications and improving maternal outcomes while helping employers retain female talent.

Products and solutions

AI-powered maternal health platform offering daily check-ins, structured clinical screening, symptom logging, early risk detection, personalised support pathways, appointment recording, and a community of mothers, employer-facing dashboard with anonymised workforce readiness scores and cohort-level insights, line manager training workshops

Unique value

The connective layer between health, work, and home — a clinical-grade maternal health infrastructure (not just a wellbeing app) that serves mothers, employers, and healthcare providers simultaneously, built on NICE-approved care pathways and developed as a regulated medical device.

Target customer

Mothers (B2C); Employers/HR teams (B2B — especially large enterprises and professional services firms); Healthcare providers (NHS GP surgeries, health systems)

Industries served

Maternal Health, Femtech, Digital Health, Employer Benefits / Workplace Wellness, Women's Health

Technology advantage

AI-powered early screening and risk stratification; registered Class I medical device (Class IIa in development); built on validated clinical screening tools and NICE-approved care pathways; research partnership with Warwick University; dyadic mother-baby approach aligned with clinical pathways; clinically moderated with Medical Advisory Board oversight

How they differentiate

Unlike general wellness apps, Matresa is being developed as a regulated medical device (Class I registered, Class IIa in preparation) with clinical-grade screening and diagnostics. It uniquely bridges the gap between healthcare and employer benefits, serving both mothers and employers with a single platform. Built on NICE-approved care pathways and validated through a Warwick University research partnership and a Big Four professional services firm pilot.

Main competitors

Maven Clinic (US), Peppy (UK), Babyscripts (US)

Key partnerships

Warwick University (research partnership — 4-month feasibility study with 400+ quantitative responses), DigitalHealth.London Accelerating FemTech: Evaluate programme (Innovate UK Biomedical Catalyst Accelerator), Big Four professional services firm (8-week pilot)

Notable customers

Big Four professional services firm (pilot, name undisclosed)

Major milestones

Founded 2025 (incorporated 10 Apr 2025), joined DigitalHealth.London Accelerating FemTech: Evaluate programme (Nov 2025-Feb 2026), raised £315K pre-seed led by SFC Capital (Jan/Feb 2026), registered as Class I medical device, 100 mothers accepted into beta (Aug 2026); platform launching September 2026, planning US expansion

Growth metrics

100 mothers in beta testing group (Aug 2026); ~7 LinkedIn-listed employees; company LinkedIn ~965 followers (Aug 2026)

Market positioning

Early-stage UK femtech startup positioned at the intersection of maternal health, AI, and employer benefits. Competes with larger US-based platforms like Maven Clinic and Babyscripts, and UK-based Peppy, but differentiates through its clinical-grade medical device approach and dual B2B/B2C model targeting both employers and healthcare providers.

Geographic focus

United Kingdom (launching September 2026); planning US expansion

About Mari-Carmen Sanchez-Morris

Former Paediatric Intensive Care Nurse at Birmingham Children's Hospital; First Class Honours in Nursing; built and bootstrapped a previous health business (fitness app); mother of three

Latest news about Matresa

More AI in Healthcare companies

Official website: